Clinical Trials in Baltimore

Showing 19801-19820 of 23,476 trials

Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid Leukemia

NCT00602771

This randomized phase II trial is studying the side effects and how well giving tipifarnib together with etoposide works in treating older patients with newly diagnosed, previously untreated acute myeloid leukemia. Tipifarnib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as etoposide, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving tipifarnib together with etoposide may kill more cancer cells.

Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+14 more

National Cancer Institute (NCI)84 participantsStarted Jan 2008

Atlanta, Georgia, United States • Baltimore, Maryland, United States • Ann Arbor, Michigan, United States +2 more locations

TERMINATEDPhase 3< 1 mile

To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older

NCT00082095

The main purpose of this study is to compare treatment with either pegylated liposomal doxorubicin or capecitabine as first line chemotherapy for metastatic breast cancer in women 60 years and older.

Metastatic Breast Cancer

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.62 participantsStarted Apr 2004

Fountain Valley, California, United States • Oxnard, California, United States • Soquel, California, United States +24 more locations

Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid Leukemia

To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older

Find Trials by Condition in Baltimore

Everolimus in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Previous Therapy

A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer

Standard Pain Control or Intrathecal Therapy in Controlling Pain in Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer

Experimental Medication For the Treatment of Generalized Anxiety Disorder

Home Vision Monitoring Using the ForeseeHome Device Following Treatment of Neovascular Age Related Macular Degeneration

Study of PET Scans and Serotonin in Hot Flashes Treatment

A Pharmacodynamic Study With Ticagrelor in African American Patients

Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD

Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder

RESPOND Restoring Equilibrium and Wound Stimulation to Promote Healing Of Non-healing DFUs

Use of Pharmacogenetics to Select Erbitux or Cisplatin to Treat Head and Neck Cancer

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease.

A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns

Assessment of Right Ventricular Volume in Tetralogy of Fallott (TOF) Patients

Study of SGN-40, Lenalidomide, and Dexamethasone in Patients With Multiple Myeloma

A Study of Trastuzumab Emtansine (T-DM1) Sequentially With Anthracycline-based Chemotherapy, as Adjuvant or Neoadjuvant Therapy for Patients With Early Stage Herceptin (HER)2-positive Breast Cancer

HMO Research Network CERT: Acute Myocardial Infarction

Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting